SCHEMBL360400

SCHEMBL360400

Cc1cc(C)c(N)c(N)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
KDM4E B2RXH2 3/20 0.56
LMNA P02545 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
TDP1 Q9NUW8 4/20 0.48
CYP3A4 P08684 5/20 0.48
TSHR P16473 4/20 0.48
TP53 P04637 2/20 0.48
ALOX15 P16050 2/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CD44 P16070 2/20 0.42
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.40
RAPGEF4 Q8WZA2 1/20 0.39
HSD17B10 Q99714 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29568340 1.00 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAGAAMAPT
Hydrochloric Acid SCHEMBL3210344 0.97 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL12968545 0.84 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL139002 0.84 ALDH1A1 (0.65) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL30578152 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL28908462 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL30578150 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT
Hydrochloric Acid SCHEMBL5621296 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT
Methane SCHEMBL2038793 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT
Bromide SCHEMBL29858695 0.81 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011311-A Preparation method of metal nanocluster confined covalent organic framework composite material 西北工业大学 2026-05-12 CN claimed
US-12304994-B2 Accelerator composition for the cure of epoxy resins with aromatic amines HUNTSMAN ADVANCED MATERIALS LICENSING (SWITZERLAND) GMBH 2025-05-20 US claimed
CN-119707829-A 2-Phenyl-benzo nitrogen-containing heterocyclic compound, and preparation method and application thereof 合肥大学 2025-03-28 CN claimed
CN-114733569-B Preparation method and application of covalent organic framework supported palladium catalyst for preparing ethylene by acetylene hydrogenation 浙江工业大学 2024-03-29 CN claimed
CN-115138380-B Preparation method and application of covalent organic framework supported copper catalyst for hydrochlorination of acetylene 浙江工业大学 2024-01-12 CN claimed
EP-3774985-B1 ACCELERATOR COMPOSITION FOR THE CURE OF EPOXY RESINS WITH AROMATIC AMINES HUNTSMAN ADV MAT LICENSING SWITZERLAND GMBH (CH) 2023-12-06 EP claimed
CN-111936545-B Accelerator composition for curing epoxy resins with aromatic amines 亨斯迈先进材料许可(瑞士)有限公司 2023-07-14 CN claimed
CN-116217612-A Preparation method of carboxyl modified cyclosiloxane, low-dielectric porous polyamide liquid crystal material and preparation method thereof 江苏久耀新材料科技有限公司 2023-06-06 CN claimed
CN-115138380-A Preparation method and application of covalent organic framework loaded copper catalyst for acetylene hydrochlorination 浙江工业大学 2022-10-04 CN claimed
CN-114733569-A Preparation method and application of covalent organic framework supported palladium catalyst for preparing ethylene by acetylene hydrogenation 浙江工业大学 2022-07-12 CN claimed
CN-111097294-A Preparation method of nanofiltration membrane for reclaimed water treatment 宁波水艺膜科技发展有限公司 2020-05-05 CN claimed
US-20200031791-A1 SHIKIMATE ANALOGUES AND METHODS OF USE THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2020-01-30 US claimed
CN-107118161-B Synthesis method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid 湖北工业大学 2019-12-31 CN claimed
CN-107118161-A The synthetic method of the carboxylic acid of 2 n-propyl, 4 tolimidazole 6 湖北工业大学 2017-09-01 CN claimed
US-20160326300-A1 CROSSLINKED EPOXY PARTICLES AND METHODS FOR MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-11-10 US claimed
WO-2015100175-A1 CROSSLINKED EPOXY PARTICLES AND METHODS FOR MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-07-02 WO claimed
EP-0411604-B1 Method and kit for determination of components KYOWA MEDEX CO LTD (JP) 1995-02-15 EP claimed
US-5246836-A Colorimetric KYOWA MEDEX CO., LTD. (JP) 1993-09-21 US claimed
EP-0411604-A2 Method and kit for determination of components KYOWA MEDEX CO.LTD. (JP) 1991-02-06 EP claimed
US-4416982-A REACTING WITH PHENOLIC COMPOUND OR ANILINE COMPOUND IN THE PRESENCE OF PEROXIDASE KYOWA HAKKO KOGYO CO., LTD. (JP) 1983-11-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031791-A1 SHIKIMATE ANALOGUES AND METHODS OF USE GRIK3, SYMPK, SIK3 ALDH1A1 2561/4885KDM4E 1644/4885LMNA 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.